{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T02:49:42Z","timestamp":1786589382346,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"DHB Foundation"},{"name":"NHMRC Senior Research Fellowship","award":["1153498"],"award-info":[{"award-number":["1153498"]}]},{"name":"Hector Maclean Scholarship"},{"name":"the University of Melbourne Annemarie Mankiewicz-Zelkin Fellowship"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Bietti crystalline dystrophy (BCD) is an inherited retinal disease (IRD) caused by mutations in the <jats:italic>CYP4V2<\/jats:italic> gene. It is a relatively common cause of IRD in east Asia. A number of features of this disease make it highly amenable to gene supplementation therapy. This study aims to validate a series of essential precursor in vitro experiments prior to developing a clinical gene therapy for BCD. We demonstrated that HEK293, ARPE19, and patient induced pluripotent stem cell (iPSC)-derived RPE cells transduced with AAV2 vectors encoding codon optimization of <jats:italic>CYP4V2<\/jats:italic> (AAV2.coCYP4V2) resulted in elevated protein expression levels of CYP4V2 compared to those transduced with AAV2 vectors encoding wild type <jats:italic>CYP4V2<\/jats:italic> (AAV2.wtCYP4V2), as assessed by immunocytochemistry and western blot. Similarly, we observed significantly increased CYP4V2 enzyme activity in cells transduced with AAV2.coCYP4V2 compared to those transduced with AAV2.wtCYP4V2. We also showed CYP4V2 expression in human RPE\/choroid explants transduced with AAV2.coCYP4V2 compared to those transduced with AAV2.wtCYP4V2. These preclinical data support the further development of a gene supplementation therapy for a currently untreatable blinding condition\u2014BCD. Codon-optimized <jats:italic>CYP4V2<\/jats:italic> transgene was superior to wild type in terms of protein expression and enzyme activity. Ex vivo culture of human RPE cells provided an effective approach to test AAV-mediated transgene delivery.<\/jats:p>","DOI":"10.1038\/s41598-022-12210-8","type":"journal-article","created":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T14:03:03Z","timestamp":1654783383000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["AAV2-mediated gene therapy for Bietti crystalline dystrophy provides functional CYP4V2 in multiple relevant cell models"],"prefix":"10.1038","volume":"12","author":[{"given":"Jiang-Hui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace E.","family":"Lidgerwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Daniszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica L.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina E.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond C. B.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandy S. C.","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle E.","family":"McClements","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex W.","family":"Hewitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"P\u00e9bay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doron G.","family":"Hickey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,9]]},"reference":[{"key":"12210_CR1","volume-title":"GeneReviews\u00ae","author":"M Vargas","year":"1993","unstructured":"Vargas, M., Mitchell, A., Yang, P. & Weleber, R. Bietti Crystalline Dystrophy. In GeneReviews\u00ae (eds Adam, M. P. et al.) (University of Washington, Seattle, 1993)."},{"key":"12210_CR2","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/s0002-9394(14)76572-9","volume":"118","author":"MI Kaiser-Kupfer","year":"1994","unstructured":"Kaiser-Kupfer, M. I. et al. Clinical biochemical and pathologic correlations in Bietti\u2019s crystalline dystrophy. Am. J. Ophthalmol. 118, 569\u2013582. https:\/\/doi.org\/10.1016\/s0002-9394(14)76572-9 (1994).","journal-title":"Am. J. Ophthalmol."},{"key":"12210_CR3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/APO.0000000000000209","volume":"5","author":"DS Ng","year":"2016","unstructured":"Ng, D. S., Lai, T. Y., Ng, T. K. & Pang, C. P. Genetics of Bietti crystalline dystrophy. Asia-Pacific J. Ophthalmol. (Philadelphia, Pa) 5, 245\u2013252. https:\/\/doi.org\/10.1097\/APO.0000000000000209 (2016).","journal-title":"Asia-Pacific J. Ophthalmol. (Philadelphia, Pa)"},{"key":"12210_CR4","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s10792-012-9686-2","volume":"33","author":"Y Song","year":"2013","unstructured":"Song, Y., Mo, G. & Yin, G. A novel mutation in the CYP4V2 gene in a Chinese patient with Bietti\u2019s crystalline dystrophy. Int. Ophthalmol. 33, 269\u2013276. https:\/\/doi.org\/10.1007\/s10792-012-9686-2 (2013).","journal-title":"Int. Ophthalmol."},{"key":"12210_CR5","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/S0140-6736(06)69740-7","volume":"368","author":"DT Hartong","year":"2006","unstructured":"Hartong, D. T., Berson, E. L. & Dryja, T. P. Retinitis pigmentosa. Lancet 368, 1795\u20131809. https:\/\/doi.org\/10.1016\/S0140-6736(06)69740-7 (2006).","journal-title":"Lancet"},{"key":"12210_CR6","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1086\/383228","volume":"74","author":"A Li","year":"2004","unstructured":"Li, A. et al. Bietti crystalline corneoretinal dystrophy is caused by mutations in the novel gene CYP4V2. Am. J. Hum. Genet. 74, 817\u2013826. https:\/\/doi.org\/10.1086\/383228 (2004).","journal-title":"Am. J. Hum. Genet."},{"key":"12210_CR7","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1124\/dmd.109.028530","volume":"37","author":"M Nakano","year":"2009","unstructured":"Nakano, M., Kelly, E. J. & Rettie, A. E. Expression and characterization of CYP4V2 as a fatty acid omega-hydroxylase. Drug Metab. Dispos. 37, 2119\u20132122. https:\/\/doi.org\/10.1124\/dmd.109.028530 (2009).","journal-title":"Drug Metab. Dispos."},{"key":"12210_CR8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/mgg3.109","volume":"3","author":"GD Astuti","year":"2015","unstructured":"Astuti, G. D. et al. Novel insights into the molecular pathogenesis of CYP4V2-associated Bietti\u2019s retinal dystrophy. Mol. Genet. Genomic Med. 3, 14\u201329. https:\/\/doi.org\/10.1002\/mgg3.109 (2015).","journal-title":"Mol. Genet. Genomic Med."},{"key":"12210_CR9","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1124\/mi.11.2.10","volume":"11","author":"EJ Kelly","year":"2011","unstructured":"Kelly, E. J., Nakano, M., Rohatgi, P., Yarov-Yarovoy, V. & Rettie, A. E. Finding homes for orphan cytochrome P450s: CYP4V2 and CYP4F22 in disease states. Mol. Interv. 11, 124\u2013132. https:\/\/doi.org\/10.1124\/mi.11.2.10 (2011).","journal-title":"Mol. Interv."},{"key":"12210_CR10","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.ajo.2004.11.065","volume":"139","author":"Y Wada","year":"2005","unstructured":"Wada, Y. et al. Screening for mutations in CYP4V2 gene in Japanese patients with Bietti\u2019s crystalline corneoretinal dystrophy. Am. J. Ophthalmol. 139, 894\u2013899. https:\/\/doi.org\/10.1016\/j.ajo.2004.11.065 (2005).","journal-title":"Am. J. Ophthalmol."},{"key":"12210_CR11","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1124\/mol.112.080085","volume":"82","author":"M Nakano","year":"2012","unstructured":"Nakano, M., Kelly, E. J., Wiek, C., Hanenberg, H. & Rettie, A. E. CYP4V2 in Bietti\u2019s crystalline dystrophy: ocular localization, metabolism of omega-3-polyunsaturated fatty acids, and functional deficit of the p.H331P variant. Mol. Pharmacol. 82, 679\u2013686. https:\/\/doi.org\/10.1124\/mol.112.080085 (2012).","journal-title":"Mol. Pharmacol."},{"key":"12210_CR12","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1167\/iovs.09-3665","volume":"51","author":"TY Lai","year":"2010","unstructured":"Lai, T. Y. et al. Alterations in serum fatty acid concentrations and desaturase activities in Bietti crystalline dystrophy unaffected by CYP4V2 genotypes. Invest. Ophthalmol. Vis. Sci. 51, 1092\u20131097. https:\/\/doi.org\/10.1167\/iovs.09-3665 (2010).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"12210_CR13","first-page":"1707","volume":"42","author":"J Lee","year":"2001","unstructured":"Lee, J. et al. The metabolism of fatty acids in human Bietti crystalline dystrophy. Invest. Ophthalmol. Vis. Sci. 42, 1707\u20131714 (2001).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"12210_CR14","doi-asserted-by":"publisher","first-page":"3936","DOI":"10.1073\/pnas.1717338115","volume":"115","author":"M Hata","year":"2018","unstructured":"Hata, M. et al. Reduction of lipid accumulation rescues Bietti\u2019s crystalline dystrophy phenotypes. Proc. Natl. Acad. Sci. U S A 115, 3936\u20133941. https:\/\/doi.org\/10.1073\/pnas.1717338115 (2018).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"12210_CR15","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a017285","volume":"5","author":"EA Pierce","year":"2015","unstructured":"Pierce, E. A. & Bennett, J. The status of RPE65 gene therapy trials: safety and efficacy. Cold Spring Harb. Perspect. Med. 5, a017285. https:\/\/doi.org\/10.1101\/cshperspect.a017285 (2015).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"12210_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57010064","author":"A Abbouda","year":"2021","unstructured":"Abbouda, A., Avogaro, F., Moosajee, M. & Vingolo, E. M. Update on gene therapy clinical trials for choroideremia and potential experimental therapies. Medicina (Kaunas) https:\/\/doi.org\/10.3390\/medicina57010064 (2021).","journal-title":"Medicina (Kaunas)"},{"key":"12210_CR17","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1089\/hum.2019.337","volume":"31","author":"C Song","year":"2020","unstructured":"Song, C. et al. Dose range finding studies with two RPGR transgenes in a canine model of X-linked retinitis pigmentosa treated with subretinal gene therapy. Hum. Gene Ther. 31, 743\u2013755. https:\/\/doi.org\/10.1089\/hum.2019.337 (2020).","journal-title":"Hum. Gene Ther."},{"key":"12210_CR18","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1126\/science.1151526","volume":"318","author":"J Yu","year":"2007","unstructured":"Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917\u20131920. https:\/\/doi.org\/10.1126\/science.1151526 (2007).","journal-title":"Science"},{"key":"12210_CR19","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1177\/2472630317712220","volume":"23","author":"M Daniszewski","year":"2018","unstructured":"Daniszewski, M. et al. Automated cell culture systems and their applications to human pluripotent stem cell studies. SLAS Technol. 23, 315\u2013325. https:\/\/doi.org\/10.1177\/2472630317712220 (2018).","journal-title":"SLAS Technol."},{"key":"12210_CR20","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1177\/2472555217696797","volume":"22","author":"DE Crombie","year":"2017","unstructured":"Crombie, D. E. et al. Development of a Modular automated system for maintenance and differentiation of adherent human pluripotent stem cells. SLAS Discov. 22, 1016\u20131025. https:\/\/doi.org\/10.1177\/2472555217696797 (2017).","journal-title":"SLAS Discov."},{"key":"12210_CR21","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1098\/rstb.2011.0016","volume":"366","author":"K Okita","year":"2011","unstructured":"Okita, K. & Yamanaka, S. Induced pluripotent stem cells: opportunities and challenges. Philos. Trans. R Soc. Lond. B Biol. Sci. 366, 2198\u20132207. https:\/\/doi.org\/10.1098\/rstb.2011.0016 (2011).","journal-title":"Philos. Trans. R Soc. Lond. B Biol. Sci."},{"key":"12210_CR22","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.gpb.2020.08.002","volume":"19","author":"GE Lidgerwood","year":"2021","unstructured":"Lidgerwood, G. E. et al. Transcriptomic profiling of human pluripotent stem cell-derived retinal pigment epithelium over time. Genomics Proteomics Bioinform. 19, 223\u2013242. https:\/\/doi.org\/10.1016\/j.gpb.2020.08.002 (2021).","journal-title":"Genomics Proteomics Bioinform."},{"key":"12210_CR23","doi-asserted-by":"crossref","unstructured":"Wang, J.-H. et al. Functional study of the AMD-associated gene TMEM97 in retinal pigmented epithelium using CRISPR interference. bioRxiv (2020).","DOI":"10.1101\/2020.07.10.198143"},{"key":"12210_CR24","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1128\/JVI.72.3.2224-2232.1998","volume":"72","author":"X Xiao","year":"1998","unstructured":"Xiao, X., Li, J. & Samulski, R. J. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J. Virol. 72, 2224\u20132232. https:\/\/doi.org\/10.1128\/JVI.72.3.2224-2232.1998 (1998).","journal-title":"J. Virol."},{"key":"12210_CR25","doi-asserted-by":"publisher","first-page":"5719","DOI":"10.1073\/pnas.92.12.5719","volume":"92","author":"DW Russell","year":"1995","unstructured":"Russell, D. W., Alexander, I. E. & Miller, A. D. DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors. Proc. Natl. Acad. Sci. U.S.A. 92, 5719\u20135723. https:\/\/doi.org\/10.1073\/pnas.92.12.5719 (1995).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"12210_CR26","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1089\/hum.2017.179","volume":"29","author":"LA Wiley","year":"2018","unstructured":"Wiley, L. A. et al. Assessment of adeno-associated virus serotype tropism in human retinal explants. Hum. Gene Ther. 29, 424\u2013436. https:\/\/doi.org\/10.1089\/hum.2017.179 (2018).","journal-title":"Hum. Gene Ther."},{"key":"12210_CR27","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/sj.bjp.0704101","volume":"133","author":"N Miyata","year":"2001","unstructured":"Miyata, N. et al. HET0016, a potent and selective inhibitor of 20-HETE synthesizing enzyme. Br. J. Pharmacol. 133, 325\u2013329. https:\/\/doi.org\/10.1038\/sj.bjp.0704101 (2001).","journal-title":"Br. J. Pharmacol."},{"key":"12210_CR28","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1006\/exer.1996.0020","volume":"62","author":"KC Dunn","year":"1996","unstructured":"Dunn, K. C., Aotaki-Keen, A. E., Putkey, F. R. & Hjelmeland, L. M. ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp. Eye Res. 62, 155\u2013169. https:\/\/doi.org\/10.1006\/exer.1996.0020 (1996).","journal-title":"Exp. Eye Res."},{"key":"12210_CR29","first-page":"1970","volume":"17","author":"G Mamatha","year":"2011","unstructured":"Mamatha, G. et al. Molecular screening of the CYP4V2 gene in Bietti crystalline dystrophy that is associated with choroidal neovascularization. Mol. Vis. 17, 1970\u20131977 (2011).","journal-title":"Mol. Vis."},{"key":"12210_CR30","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1159\/000331885","volume":"2","author":"Y Yokoi","year":"2011","unstructured":"Yokoi, Y. et al. A novel compound heterozygous mutation in the CYP4V2 gene in a Japanese patient with Bietti\u2019s crystalline corneoretinal dystrophy. Case Rep. Ophthalmol. 2, 296\u2013301. https:\/\/doi.org\/10.1159\/000331885 (2011).","journal-title":"Case Rep. Ophthalmol."},{"key":"12210_CR31","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.bbalip.2018.04.007","volume":"1863","author":"GE Lidgerwood","year":"2018","unstructured":"Lidgerwood, G. E. et al. Role of lysophosphatidic acid in the retinal pigment epithelium and photoreceptors. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1863, 750\u2013761. https:\/\/doi.org\/10.1016\/j.bbalip.2018.04.007 (2018).","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"12210_CR32","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/ICU.0000000000000660","volume":"31","author":"DA Prado","year":"2020","unstructured":"Prado, D. A., Acosta-Acero, M. & Maldonado, R. S. Gene therapy beyond luxturna: a new horizon of the treatment for inherited retinal disease. Curr. Opin. Ophthalmol. 31, 147\u2013154. https:\/\/doi.org\/10.1097\/ICU.0000000000000660 (2020).","journal-title":"Curr. Opin. Ophthalmol."},{"key":"12210_CR33","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1016\/j.ymthe.2020.07.024","volume":"28","author":"Z Zhang","year":"2020","unstructured":"Zhang, Z. et al. PSCs Reveal PUFA-provoked mitochondrial stress as a central node potentiating RPE degeneration in Bietti\u2019s crystalline dystrophy. Mol. Ther. J. Am. Soc. Gene Ther. 28, 2642\u20132661. https:\/\/doi.org\/10.1016\/j.ymthe.2020.07.024 (2020).","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"12210_CR34","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/s41434-020-0159-3","volume":"27","author":"B Qu","year":"2020","unstructured":"Qu, B. et al. Treating Bietti crystalline dystrophy in a high-fat diet-exacerbated murine model using gene therapy. Gene Ther. 27, 370\u2013382. https:\/\/doi.org\/10.1038\/s41434-020-0159-3 (2020).","journal-title":"Gene Ther."},{"key":"12210_CR35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.omtm.2018.01.004","volume":"9","author":"HC Brown","year":"2018","unstructured":"Brown, H. C. et al. Target-cell-directed bioengineering approaches for gene therapy of hemophilia A. Mol. Ther. Methods Clin. Dev. 9, 57\u201369. https:\/\/doi.org\/10.1016\/j.omtm.2018.01.004 (2018).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"12210_CR36","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1016\/j.ymthe.2017.05.005","volume":"25","author":"MD Fischer","year":"2017","unstructured":"Fischer, M. D. et al. Codon-optimized RPGR improves stability and efficacy of AAV8 gene therapy in two mouse models of X-Linked retinitis pigmentosa. Mol. Ther. J. Am. Soc. Gene Ther. 25, 1854\u20131865. https:\/\/doi.org\/10.1016\/j.ymthe.2017.05.005 (2017).","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"12210_CR37","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/gt.2016.66","volume":"23","author":"A Georgiadis","year":"2016","unstructured":"Georgiadis, A. et al. Development of an optimized AAV2\/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65. Gene Ther. 23, 857\u2013862. https:\/\/doi.org\/10.1038\/gt.2016.66 (2016).","journal-title":"Gene Ther."},{"key":"12210_CR38","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.2147\/OPTH.S185744","volume":"13","author":"GP Garcia-Garcia","year":"2019","unstructured":"Garcia-Garcia, G. P., Martinez-Rubio, M., Moya-Moya, M. A., Perez-Santonja, J. J. & Escribano, J. Current perspectives in Bietti crystalline dystrophy. Clin. Ophthalmol. 13, 1379\u20131399. https:\/\/doi.org\/10.2147\/OPTH.S185744 (2019).","journal-title":"Clin. Ophthalmol."},{"key":"12210_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20174274","author":"YB Jarrar","year":"2019","unstructured":"Jarrar, Y. B. & Lee, S. J. Molecular functionality of cytochrome P450 4 (CYP4) genetic polymorphisms and their clinical implications. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms20174274 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"12210_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094960","volume":"9","author":"H Yin","year":"2014","unstructured":"Yin, H. et al. Molecular analysis and phenotypic study in 14 Chinese families with Bietti crystalline dystrophy. PLoS ONE 9, e94960. https:\/\/doi.org\/10.1371\/journal.pone.0094960 (2014).","journal-title":"PLoS ONE"},{"key":"12210_CR41","doi-asserted-by":"publisher","first-page":"5572","DOI":"10.1167\/iovs.13-13717","volume":"55","author":"CM Lockhart","year":"2014","unstructured":"Lockhart, C. M., Nakano, M., Rettie, A. E. & Kelly, E. J. Generation and characterization of a murine model of Bietti crystalline dystrophy. Invest. Ophthalmol. Vis. Sci. 55, 5572\u20135581. https:\/\/doi.org\/10.1167\/iovs.13-13717 (2014).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"12210_CR42","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/978-1-4939-7522-8_21","volume":"1715","author":"HO Orlans","year":"2018","unstructured":"Orlans, H. O., Edwards, T. L., De Silva, S. R., Patricio, M. I. & MacLaren, R. E. Human retinal explant culture for Ex vivo validation of AAV gene therapy. Methods Mol. Biol. 1715, 289\u2013303. https:\/\/doi.org\/10.1007\/978-1-4939-7522-8_21 (2018).","journal-title":"Methods Mol. Biol."},{"key":"12210_CR43","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/gt.2017.85","volume":"24","author":"DG Hickey","year":"2017","unstructured":"Hickey, D. G. et al. Tropism of engineered and evolved recombinant AAV serotypes in the rd1 mouse and ex vivo primate retina. Gene Ther. 24, 787\u2013800. https:\/\/doi.org\/10.1038\/gt.2017.85 (2017).","journal-title":"Gene Ther."},{"key":"12210_CR44","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1034\/j.1399-0004.2000.570501.x","volume":"57","author":"G Clarke","year":"2000","unstructured":"Clarke, G., Heon, E. & McInnes, R. R. Recent advances in the molecular basis of inherited photoreceptor degeneration. Clin. Genet. 57, 313\u2013329. https:\/\/doi.org\/10.1034\/j.1399-0004.2000.570501.x (2000).","journal-title":"Clin. Genet."},{"key":"12210_CR45","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jmb.2008.08.012","volume":"383","author":"CJ Tsai","year":"2008","unstructured":"Tsai, C. J. et al. Synonymous mutations and ribosome stalling can lead to altered folding pathways and distinct minima. J. Mol. Biol. 383, 281\u2013291. https:\/\/doi.org\/10.1016\/j.jmb.2008.08.012 (2008).","journal-title":"J. Mol. Biol."},{"key":"12210_CR46","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.meegid.2013.02.017","volume":"16","author":"JH Zhou","year":"2013","unstructured":"Zhou, J. H. et al. The effects of the synonymous codon usage and tRNA abundance on protein folding of the 3C protease of foot-and-mouth disease virus. Infect. Genet. Evol. 16, 270\u2013274. https:\/\/doi.org\/10.1016\/j.meegid.2013.02.017 (2013).","journal-title":"Infect. Genet. Evol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12210-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12210-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12210-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T04:02:45Z","timestamp":1669348965000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12210-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,9]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["12210"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-12210-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,9]]},"assertion":[{"value":"24 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9525"}}